New medicines for multiple sclerosis have made a big difference in patients' lives, but a breakthrough in therapy may require rethinking the origins of the disease
Six years ago, when she was 24, Rachelle Alston woke up one morning and noticed she was having trouble seeing out of her left eye. “Everything was blurry from the bridge of my nose down,” recalls the slim Seattle native. “I thought my contacts must have scratched my eye or I had dry eyes, so I left my contacts out and went to work.”